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The precursor protein, pro-opiomelanocortin (POMC) undergoes extensive post-
translational processing in a tissue-specific manner to yield various biologically active
peptides involved in diverse cellular functions. The recently developed method of matrix-
assisted laser desorption/ionization mass spectrometry (MALDI-MS) for direct tissue analy-
sis has proved to be a powerful tool for investigating the distribution of peptides and
proteins. In particular, topological mass spectrometry analysis using MALDI-MS can selec-
tively provide a mass profile of the hormones included in cell secretory granules. An
advantage of this technology is that it is possible to analyze a frozen thin slice section,
avoiding an extraction procedure. Subsequently, tandem mass spectrometry (MS/MS) has
a profound impact on addressing the modified residues in the hormone molecules. Based
on these strategies with mass spectrometry, several interesting molecular forms of POMC-
derived peptides have been found in the fish pituitary, such as novel sites of acetylation
in α-melanocyte-stimulating hormone (MSH), hydroxylation of a proline residue in β-MSH,
and the phosphorylated form of corticotropin-like intermediate lobe peptide.
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INTRODUCTION
It is now recognized that pituitary hormones such as melanocyte-
stimulating hormone (MSH), corticotropin-like intermediate lobe
peptide (CLIP), and endorphin (END), are processing products
of a common precursor protein, pro-opiomelanocortin (POMC).
This knowledge was discovered through traditional endocrine
research and nucleotide sequencing of the cloned cDNA for
the POMC precursor. In 1916, the first demonstrations that the
pituitary is involved in controlling skin color were found when
hypophysectomy of tadpoles caused a skin lightening, while injec-
tion of pituitary extracts produced skin darkening (1, 2). The
development of assays was then devised to test the response
to the melanocyte-stimulating factors (3), for control of the
adrenal cortex (4), and for opiate-like actions (5). The strat-
egy using the bioassay is the commonly accepted approach for
the purification of pituitary hormones. Nakanishi et al. (6) first
reported the nucleotide sequence of a cloned cDNA encoding
bovine corticotropin and β-lipotropin precursor, which consists
of repetitive units of melanotropin, CLIP, and END sequences.
Electron microscopy was applied to pituitary studies in 1950s.
These revealed that secretory proteins are temporarily stored
within special storage granules and subsequently secreted into
the blood stream. In the late 1960s, there were several attempts
to isolate secretory granules in an application of ultracentrifu-
gation, and then the bioassay and granule measurement sup-
porting the ultrastructural identification of the pituitary cell
types were reported by many investigators. After 30 years of
these types of studies, matrix-assisted laser desorption/ionization
with time-of-flight mass spectrometry (MALDI-TOF MS) was
developed to analyze the secretory granules directly in frozen
sections. In this review we shall focus on recent studies of the
post-translational modifications that have been found in POMC-
derived peptides in fish pituitary, starting with a background on
the application of mass spectrometry that has been used for these
studies.
DIRECT TISSUE ANALYSIS USING MALDI-TOF MS
The origin of direct laser desorption/ionization for mass spectral
analysis may be traced to the early 1960s (7). This technology
evolved into the laser microprobe mass analyzer (LAMMA) as a
tool for medical and biological samples that could be aimed at a
region of interest in a histological microtome section (8). Interpre-
tation of the LAMMA spectra subsequently led to the discovery of
the MALDI principle in 1985 (9). Recently, MALDI imaging mass
spectrometry (IMS) has emerged as a new method that allows
mapping of a wide range of biomolecules within a thin tissue
section [see, Ref. (10)]. Independently of, and parallel to IMS stud-
ies, we proposed “topological mass spectrometry analysis” (11) as
a strategy based on an application of MALDI-TOF MS analysis
that allows for the search for novel hormones and neuropeptides.
A key benefit in our method of sample preparation is that, while
the ion peaks generally could not be detected in the frozen slices
of an endocrine gland or neuron prepared at a 30–40µm thick-
nesses, significant signaling in the spectrum could be measured
specifically from the secretory cells irradiated by the laser light.
The resulting spectrum indicates that MALDI-TOF MS selectively
provides a mass profile of the peptides and proteins derived from
cell secretory granules. Our hypothesis is that selective detection
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of secretory granules seems to be caused by proton capture of
granules during MALDI ion formation, and not by other cellular
components. Another benefit of direct tissue MALDI-TOF MS is
that any enzymatic event in the sample preparation is suppressed
by the matrix solution, which possesses a strong inhibitory effect.
Thus, instead of a bioassay, the resulting molecular weight becomes
an index of hormone purification. In contrast, IMS peak intensity
and the number of observed peaks are prominently increased by
the thinness of a slice decreased to <10µm, in which most of the
ion peaks seem to be from substances of cytoplasmic origin. Topo-
logical mass spectrometry analysis comprises three steps. The first
one is the site-specific molecular mass profiling of the peptides
and proteins contained in the secretory granules by direct tissue
analysis using MALDI-TOF MS. The identification of hormones is
accomplished by matching the observed masses to the theoretical
masses derived from a sequence database. Thus, the unidentified
ion peaks in the spectrum may suggest the presence of a novel
candidate hormone or a modified hormone in the pituitary. In the
interpretation of the resulting spectrum, it is interesting that mass
differences such as −1, 16, 42, and 80 Da correspond to carboxy-
terminal amidation, oxidation, or hydroxylation, acetylation, and
phosphorylation, respectively. This rule can be applied to predict
the modified residue in a hormone. The second step is purifi-
cation of a given peptide from the tissue extract by monitoring
of the resulting mass number, and then sequencing the peptide
using a protein sequencer or tandem mass spectrometry (MS/MS)
analysis. The third step is molecular cloning to determine the pre-
cursor sequence corresponding to the isolated peptides. The liquid
chromatography (LC) MS/MS analysis is also available to deter-
mine the mature molecules with post-translational modifications.
Application of topological mass spectrometry analysis is widely
used in the fields of endocrinology and neuroscience in fish, crus-
taceans, insects, and plants (12–20). Among them, the medaka
pituitary provides a unique spectrum in direct MALDI-TOF MS
that was the basis of the first report of the structural determina-
tion of tri-acetylated and hydroxylated POMC-related hormone
in vertebrates (19).
ACETYLATION
Acetylation is a major modification in POMC-derived peptides,
such as α-MSH and END. α-MSH is mainly produced in the pitu-
itary and controls melanosome dispersion in melanocytes. The
structure of α-MSH is characterized as a tri-decapeptide including
an amino-terminal acetylation and a carboxy-terminal amidation
that is identical in most vertebrates. Structural variations of α-
MSH were first found in bovine pituitary as the diacetyl form (21),
and identified from salmon pituitary as the non-acetylated form
(22). Recently, based on topological mass spectrometry analy-
sis, we have reported that four molecular forms, N -desacetyl-,
monoacetyl-, diacetyl-, and triacetyl-α-MSH, were present in
medaka pituitary as shown in Figure 1 (19). Tandem mass spec-
trometry (MS/MS) analysis has shown that N,O-diacetylation of
the Ser residue at position 1 was deduced from diacetyl-α-MSH,
and N,O-diacetylation of that same Ser residue at position 1 and
O-acetylation of the Ser residue at position 3 from triacetyl-α-
MSH. In an earlier study on fish endocrinology, N -desacetyl-,
monoacetyl-, and diacetyl-α-MSH were identified from two
species of Cyprinidae: goldfish and carp (23). More recently, when
we have checked pituitary further in carp and goldfish using direct
MALDI-TOF MS, the existence of triacetyl-α-MSH was observed.
However, in a comparison of triacetyl-α-MSH between medaka
and carp/goldfish with MS/MS, the resulting spectra were differ-
ent from each other. The N,O-diacetylation of the Ser residue at
position 1 and O-acetylation of the Tyr residue at position 2 in
the triacetyl-α-MSH molecule were deduced in carp and goldfish
(20). The acetylation reaction of the α-MSH molecule starts with
the amino group on the Ser residue at position 1, and then act
with the hydroxyl group at the N-terminal Ser residue. A defini-
tive O-acetylation for [N,O-diacetyl Ser1]-α-MSH may vary from
species to species.
We have carried out a physiological study using a MALDI-
TOF MS that directly analyzes and measures those hormones. The
percentages as a total of α-MSH molecules were compared for
medaka and goldfish reared in a white or black tank for 5 days.
Among structural variants, diacetyl-α-MSH was the predominant
FIGURE 1 | Post-translational modifications of melanotropins in the pituitary.
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FIGURE 2 | Phosphorylation of ACTH and CLIP molecules in the pituitary.
form in goldfish and N -desacetyl-α-MSH in medaka, respectively.
In both species, the relative level of the predominant form in the
pituitary of white-adapted fish tended to be lower than that of
black-adapted fish, but no significant difference was observed in
the relative content of goldfish triacetyl-α-MSH in both back-
grounds. Furthermore, the lowest content of triacetyl-α-MSH was
found in black-adapted medaka. These preliminary data beg the
question of how the physiological events regulate the variation in
α-MSH levels or the different pattern of acetylation of α-MSH in
the fish pituitary.
HYDROXYLATION
Hydroxylation of the proline residue in the pituitary hormones
has never been found previously. Recently, we reported the exis-
tence of a hydroxyproline (Hyp) residue in the β-MSH molecule in
medaka pituitary (19). β-MSH is a slightly basic peptide and there
are some variations between different species. A post-translational
modification of the β-MSH molecule was not previously observed
in any species. In fact, direct tissue MALDI-TOF MS analysis using
tissue slices from carp, goldfish, rainbow trout, etc. indicated that
β-MSH containing a Hyp residue was not present. Thus, β-MSH
is an enigmatic hormone with hydroxylation of melanotropin,
restricted to β-MSH in the medaka species, and a physiological
role of β-MSH in teleost fish has not yet been elucidated. On the
other hand, in mammalian and frog hypothalamus, an endoge-
nous, hydroxylated post-translational product of the luteinizing
hormone-releasing hormone sequence [Hyp9]-LHRH, has been
isolated (24). In rodent, the [Hyp9]-LHRH may play a specific
role in development, as [Hyp9]-LHRH is the major molecular
form in the fetal rat hypothalamus, but is less potent than LHRH
on gonadotropin secretion.
PHOSPHORYLATION
The structure of CLIP is known as a C-terminal fragment of the
adrenocorticotropic hormone (ACTH) sequence. A phosphory-
lated form of CLIP has been identified in rat pituitary (25), in
which a serine residue at position 14 is phosphorylated (O-pSer).
The location of the O-pSer residue in medaka CLIP is in a similar
position to that of the rat CLIP. In addition, similar to rat and
human ACTH, the lamprey ACTH is partially phosphorylated at
the Ser residue at position 35 as shown in Figure 2 (16). In compar-
ing mammalian ACTH and CLIP, the sequence of -Ser-Ala-Glu- is
part of the signal for possible phosphorylation of the Ser residue.
In fish hormones, the sequence of -Ser-Ser-Glu- in medaka CLIP
and sequence of -Ser-Pro-Glu- in lamprey ACTH are observed. In
contrast, in porcine ACTH, a leucine residue is found at position
31 instead of a serine residue (26). So far, a phospho-ACTH or
phospho-CLIP have not been found in porcine samples. Thus, a
consensus sequence of Ser-X-Glu seems to be a signal of phos-
phorylation in the pituitary hormone. However, the physiological
role of phosphorylation in ACTH and CLIP molecules as a pri-
mary messenger remains to be elucidated in any vertebrate species
including the lamprey.
CONCLUSION AND RECOMMENDATIONS
Mass spectrometry has developed into the method for identifying
proteins and elucidating their post-translational modifications, by
using the amino acid sequence in a public database. Most POMC-
derived peptides undergo some form of modification following
translation. In recent studies, multiple forms of hormones with
post-translational modifications, such as acetylation, hydroxyla-
tion, and phosphorylation, can be identified in fish pituitary. These
modifications result in mass changes that are detected during
analysis, such as topological mass spectrometry. As a result, the
mass spectrometric analysis of these post-translational modifi-
cations is particularly important in endocrine research. Further-
more, direct tissue analysis using MALDI-TOF MS is an analyzable
experimentation if there is one only pituitary and if there are
just several minutes. Thus, this strategy is becoming an essential
tool for endocrine researchers to elucidate molecular mechanisms
within cellular systems. On the other hands, the post-translational
modifications of hormone seem to be involved in diverse func-
tions. However, the physiological significance of the modified
hormones remains to be elucidated. It is, therefore, necessary to
clear a physiologic role about the multiplicity of pituitary hormone
in the future.
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